Elitech | GenomeWeb

Elitech

NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.

Canon has been awarded US Patent No. 8,466,272, "Probe set and method for identifying HLA allele."
Mamoru Tsukada has been named as inventor on the patent.

GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.

The vote of confidence is a stepping stone for the company to seek 510(k) approval for an H1N1 test on its platform; to tackle the point-of-care diagnostic market; and to further develop tests for other infectious diseases.

While the amount of the funding was not disclosed, an official from the investment firm that founded Mirina said that it is sufficient to fund the company's operations for 12 to 15 months.

Yacob Ofer, president of Gamida's diagnostics business, said that the acquisition of NanoChip array assets from Elitech gives the firm the ability to continue to service the "large and growing" number of customers in Israel.

Gamida has acquired the array technology that Elitech bought from Nanogen last year.

IP Roundup

Premium

Nanogen, Universitat Konstanz, the University of Chicago, PerkinElmer, Microsoft, Yeda Research and Development

IP Roundup

Premium

CapitalBio, Population Genetics Technologies, Illumina, Nanogen, Gen-Probe, BioArray Solutions, Fluidigm

People in the News

Premium

Christian Henry, Howard Birndorf, David Schreiber, Robert Whalen, Stelio Papadopoulos, Heiner Dreismann, Graham Lidgard, David Ludvigson, Nicholas Venuto, John Sweeney, Joan Wilson

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.